enVVeno Medical Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NVNO, updated each market day.
NVNO AI Sentiment
AI sees no strong directional signal for enVVeno Medical Corporation Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About enVVeno Medical Corporation Common Stock
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Sector
Exchange
Market Cap
$7,243,507
Cap Tier
Employees
33
Headquarters
IRVINE, CA
Listed Since
May 31, 2018
Website
NVNO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NVNO Volatility
enVVeno Medical Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
